Curevac withdraws MAA of CVnCoV
German CureVac N.V. has withdrawn its application for market approval of its COVID-19 vaccine candidate and will focus on the development of a second-generation vaccine.
Delivering on Europe´s Green Deal EFIB 2021 in Vienna
Leading industry leaders, SMEs representatives and academia are joining in Vienna, Austria, at the 14th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB), from 6th to 7th of October, organised by EuropaBio and conference partners.
COVID-19 immunisation set to get FDA EUA
Pharma giant AstraZeneca has submitted data to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its antibody duo AZD7442.
BioNTech investigates cancer vaccine BNT122 in Phase II trial
BionTech SE, which has been very successful in the field of corona vaccines, is starting phase II tests with its colorectal cancer candidate BNT122.
Advent France Biotechnology launches 86m fund
Advent France Biotechnologys has launched a second biotech seed fund with a first close at 86m. Since 2017, the French state fund has financed 15 startups in France, Spain, Belgium and Ireland with 68m.
Team identifies factors for COVID-19 vaccine protection
A comparison of immune correlates of AstraZeneca’s Phase II/III COVID-19 vaccine trial shows what antibodiy titer is required to prevent symptomatic disease.
EIF supports translational med with 25m
The EIF has invested 25m in the Prague-based i&i Biotech Fund I to boost biomedical tech transfer in Austria and Eastern Europe.
AstraZeneca puts 307m in Irish Alexion plant
Following the $39bn Alexion buy-out completed in July, AstraZeneca plc announced it will invest 307m in the company’s producion site near Dublin.
Touchlight extends funding round to boost DNA vector manufacture
UK-based DNA synthesis specialist Touchlight Ltd has extended a funding round to a current aggregate total of US $125m.
Swiss Biotech Day shows great biopharma ambitions
The Swiss biopharmaceutical industry is on the verge of record growth: This was demonstrated at the live Swiss Biotech Day in Basel.